| 存储条件 |
|---|
| Product Name | CD183 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | CXCR3; GPR9; MigR; CD182; Mig-R; CKR-L2; CMKAR3; IP10-R |
| Immunogen | Purified recombinant fragment of human CD183 (AA: extra mix) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBIHCFCMICC/IF |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. | |
| Species Reactivity | Human |
| Alternative Names | CXCR3 GPR9 MigR CD182 Mig-R CKR-L2 CMKAR3 IP10-R |
|---|---|
| Molecular Weight(MW) | 40.7kDa |
| Entrez Gene | 2833 |
|---|
Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Application
Figure 2:Western blot analysis using CD183 mAb against human CD183 (AA: extra mix) recombinant protein. (Expected MW is 38.3 kDa)
Application
Figure 3:Western blot analysis using CD183 mAb against HEK293 (1) and CD183 (AA: extra mix)-hIgGFc transfected HEK293 (2) cell lysate.
Application
Figure 4:Western blot analysis using CD183 mouse mAb against Hela (1) and L-02 (2) cell lysate.
Application
Figure 5:Flow cytometric analysis of HL-60 cells using CD183 mouse mAb (green) and negative control (red).
Application
Figure 6:Flow cytometric analysis of Jurkat cells using CD183 mouse mAb (green) and negative control (red).
Application
Figure 7:Immunohistochemical analysis of paraffin-embedded bladder cancer tissues using CD183 mouse mAb with DAB staining.| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS with 0.05% sodium azide |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
抱歉，暂无相关文献
